This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents. Top assignee: Wyeth. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: David Jaeger - Innovator in Pharmaceutical Composition
Introduction
David Jaeger is a notable inventor based in Chester, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the efficacy of oral medications. His work focuses on creating solutions that improve the delivery of pharmaceutical actives.
Latest Patents
David Jaeger holds a patent for a pharmaceutical suspension composition. This aqueous oral liquid pharmaceutical composition system is designed with a reduced propensity for agglomeration and phase separation. It is particularly amenable to the suspension of one or more pharmaceutical actives that are substantially insoluble in water. The composition may also include pharmaceutical actives that are soluble in water, allowing them to dissolve in the aqueous medium. Importantly, both suspended and dissolved active agents are distributed homogeneously within the composition.
Career Highlights
David Jaeger is associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on innovative solutions that address challenges in drug formulation and delivery. His contributions have been instrumental in advancing the field of pharmaceutical sciences.
Collaborations
Throughout his career, David has collaborated with several talented individuals, including Jay Dickerson and William Antonio Mark. These collaborations have fostered an environment of innovation and creativity, leading to the development of effective pharmaceutical solutions.
Conclusion
David Jaeger is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact on the industry. His innovative approach to drug formulation continues to influence the development of effective oral medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
